Home › U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen...
 

Keywords :   


U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen...

2013-12-14 19:29:39| Biotech - Topix.net

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera for use in certain virologically-suppressed and St. John's wort.

Tags: single tablet fda approves

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »